Dingyi Wang

Dingyi Wang

Auto-generated profile, based on publicly available information

Dingyi Wang

National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College; Department of Clinical research and Data management, Center of Respiratory Medicine China‐Japan Friendship Hospital Beijing China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2020 in Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
DWDingyi Wang
Dingyi Wang
GFGuohui Fan
Guohui Fan
Xin LiuXin Liu
Xin Liu
SWSinan Wu
Sinan Wu
ZZZhenguo Zhai
Zhenguo Zhai
Background This article evaluates the association between renal insufficiency and short-term outcomes among patients with acute pulmonary embolism. Methods The literature search was completed on December 31, 2019 and data were contracted from 13 cohort studies. Diagnosis of renal insufficiency was based on estimated glomerular filtration rate (eGFR), serum creatinine level, or self-report. The primary outcome was all-cause mortality of 30 days or during hospitalization. The pooled risk ratios (RRs), pooled mortality rates, and between-study heterogeneity were estimated by random-effect models. All the statistical analyses were performed using STATA/SE software. Results We included 13 studies (N = 35,662) in the meta-analysis, including two focused on acute kidney injury (AKI). Early all-cause mortality in patients with versus without renal insufficiency were 15% (95% confidence interval [CI] 9–22%) and 5% (95% CI 3–8%), respectively (RR 1.76, 95% CI 1.61–1.92). For patients with eGFR < 30 mL/min·1.73m−2, rates were 30% (95% CI 11–75%) versus 10% (95% CI 5–14%) (RR 3.32, 95% CI 1.53–6.70). For patients with AKI during hospitalization, rates were 32% (95% CI 11–75%) versus 13% (95% CI 4–29%) (RR 2.69, 95% CI 1.24–5.84). Pulmonary embolism (PE)-related death and fatal bleeding were significantly higher in patients with renal insufficiency. Conclusion Renal insufficiency, especially AKI and severe renal insufficiency, was associated with early mortality in acute PE patients. Our results may escalate vigilance in risk stratification and management of PE patients with renal insufficiency in clinical practice.

4 June 2021 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
PDF file
XTXunliang Tong
Xunliang Tong
DWDingyi Wang
Dingyi Wang
HWHe Wang
He Wang
YLYixuan Liao
Yixuan Liao
YSYimeng Song
Yimeng Song
YLYanming Li
Yanming Li
Background: Consideration of the huge burden both of tuberculosis (TB) and diabetes mellitus (DM) in China as a major public health issue, research focused on the relationship between DM and TB was needed.Methods: An observational study was conducted (2015‐2018) in regional representative TB and lung disease hospitals in China. All the adult patients newly diagnosed of pulmonary TB were consecutively recruited in this study.Results: A total of 1417 patients newly diagnosed pulmonary TB was recruited in this research, 312 (22.02%) of them had the history of type 2 DM. Majority of patients were with fatigue, loss of weight and mild anaemia in TB‐DM group compared with TB‐NDM group (58.3% vs 47.5%, p = .001; 8.21 ± 6.2 vs 5.74 ± 4.0 kg, p < .001, 88.9% vs 77.6% p = .021). TB‐DM patients were with higher the proportion of TB severity score ≥3, compared with TB‐NDM patients, but the distributions of drug susceptibility testing (DST) analysis were not significantly different between the two groups of patients. Remarkably, the sign of central shadow of pulmonary lobe distribution and cavity in TB‐DM group presented significantly higher rate than it in TB‐NDM group. Multivariable logistic regression showed that high uric acid level was an independent risk factor for thick wall cavity in TB‐DM patients (OR 2.81, 95% CI 1.24‐6.40), haemoptysis (OR 2.43, 95% CI 1.10‐5.38) and chest pain (OR 5.22, 95% CI 1.38‐19.70) were significantly associated with thick wall cavity.Conclusions: The clinical features of TB‐DM patients are associated with cavities in CT scan, rather than DST results. It can help us recognition confounding variables, also may influence the treatment strategy and outcomes in TB‐DM patients.

5 February 2024 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
SMShuangshuang Ma
Shuangshuang Ma
GFGuohui Fan
Guohui Fan
FXFeiya Xu
Feiya Xu
XZXiaomeng Zhang
Xiaomeng Zhang
YCYinong Chen
Yinong Chen
CWChen Wang
Chen Wang
Patients with venous thromboembolism (VTE) comorbid renal insufficiency (RI) are at higher risk of bleeding and thrombosis. Recommendations in guidelines on anticoagulation therapy for those patients remain ambiguous. The goal of this study is to compare the efficacy and safety between different anticoagulant regimens in VTE patients comorbid RI at different stages of treatment and prophylaxis. We performed English-language searches of Pubmed, EMBASE, and Web of Science (inception to Nov 2022). RCTs evaluated anticoagulants for VTE treatment at the acute phase, extension phase, and prophylaxis in patients with RI and reported efficacy and safety outcomes were selected. The methodological quality of the studies was assessed at the outcome level using the risk-of-bias assessment tool developed by the Cochrane Bias Methods Group. A meta-analysis of twenty-five RCTs was conducted, comprising data from twenty-three articles, encompassing a total of 9,680 participants with RI. In the acute phase, the risk of bleeding was increased with novel oral anticoagulants (NOACs) compared to LMWH (RR 1.29, 95% CI 1.04–1.60). For the prophylaxis of VTE, NOACs were associated with an elevated risk of bleeding compared with placebo (RR 1.31, 95%CI 1.02–1.68). In comparison to non-RI patients, both NOACs and vitamin K antagonists (VKA) could increase the risk of bleeding among RI patients (RR 1.45, 95%CI 1.14–1.84 and RR 1.53, 95%CI 1.25–1.88, respectively) during acute phase, while NOACs may increase the incidence of VTE in RI population (RR 1.74, 95%CI 1.29–2.34). RI patients who are under routine anticoagulation have a significantly higher risk of adverse outcomes. LMWH is the most effective and safe option for VTE treatment or prophylaxis in patients with RI.

29 August 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
DWDingyi Wang
Dingyi Wang
GFGuohui Fan
Guohui Fan
YLYanshuang Lyu
Yanshuang Lyu
XXXiaomao Xu
Xiaomao Xu
QLQin Luo
Qin Luo
ZZZhenguo Zhai
Zhenguo Zhai
Objective We aimed to investigate the risk factors for acute kidney injury (AKI) after normotensive pulmonary embolism (PE) and the impact of anticoagulation on renal recovery. Design Multicentred, retrospective cohort study. Setting Data from four tertiary hospitals in China were captured. All available measurements of serum creatinine (SCr) during hospitalisation and follow-up were collected. Participants Patients with acute PE and those without haemodynamic instability were enrolled. All recruited patients were followed up for up to 2 years. Primary and secondary outcome measures The primary outcome was the occurrence of AKI, defined by the Kidney Disease Improving Global Outcomes criteria. The secondary outcome was the recovery of renal function. The time interval between PE onset and the initiation of anticoagulation was analysed to obtain its influence on the recovery of renal function. Results A total of 461 patients with acute normotensive PE were enrolled. A transient elevation of SCr during hospitalisation was observed. The incidence of AKI among normotensive patients was 18.9%. Brain natriuretic peptide (BNP) NT-proBNP elevation (adjusted HR (aHR) 2.27, 95% CI 1.33 to 3.86) and history of chronic kidney disease (aHR 4.81, 95% CI 2.44 to 9.48) were associated with the development of AKI during hospitalisation. Earlier initiation of anticoagulation therapy (within 5 days after PE onset, compared with over 6 days) promoted an early recovery of renal function (adjusted OR 0.26, 95% CI 0.08 to 0.84, p=0.025). Conclusions Renal impairment and AKI were highly prevalent among patients with normotensive patients. The occurrence of AKI was associated with right heart function. Patients who developed AKI after PE would benefit from earlier anticoagulation therapy for an early recovery of renal function.

3 July 2025 in Kidney Medicine
Verified
Journal Article
Open access
GFGuohui Fan
Guohui Fan
XLXin Liu
Xin Liu
FXFeiya Xu
Feiya Xu
XZXiaomeng Zhang
Xiaomeng Zhang
CSChaozeng Si
Chaozeng Si
DWDingyi Wang
Dingyi Wang
Lymphopenia may have a potential mechanism on the development of acute kidney injury (AKI) after respiratory virus infection but has never been revealed. We aimed to investigate the relationship between lymphopenia and AKI in patients hospitalized with respiratory virus infections. A single-center and retrospective cohort study. Data were retrospectively collected from electronic medical records of patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza, or other respiratory virus infections from 2016- 2023. Prolonged lymphopenia (<1.1 × 109/L) was defined as continuous lymphopenia lasting for ≥1 day before AKI diagnosis. Serial measurements of serum creatinine levels and lymphocyte counts before AKI were collected. AKI developed after infection was identified according to the KDIGO guideline. Multivariable logistic regression models and Cox proportional regression models were conducted to evaluate associations between lymphopenia or blood count ratios and AKI. A total of 3,104 patients were analyzed, including 1,945 infected with SARS-CoV-2, 597 with influenza, and 472 with other respiratory virus infections. The AKI incidences were 18.0%, 23.3%, and 16.3%, respectively. Serum creatinine level was significantly negatively correlated with lymphocyte count in SARS-CoV-2 and influenza infections. Multivariable regression showed lymphopenia, especially prolonged lymphopenia, was significantly associated with AKI in all virus groups, especially in influenza. The risk magnitudes of monocyte-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on admission for AKI varied by different viral infections. Lymphopenia or not was not associated with AKI stages or AKI recovery. The results were limited by the retrospective, single-center setting and the probability of underestimation of the prevalence of both lymphopenia and AKI. Lymphopenia, especially prolonged lymphopenia, and neutrophil-to-lymphocyte ratio on admission were risk factors for AKI after respiratory virus infection, with the highest risk observed in patients with influenza.

25 September 2025 in Renal Failure
Verified
Journal Article
Open access
XLXin Liu
Xin Liu
DWDingyi Wang
Dingyi Wang
YCYalin Cheng
Yalin Cheng
HLHuimin Li
Huimin Li
YLYuzhu Lu
Yuzhu Lu
WZWenduo Zhang
Wenduo Zhang
We aimed to investigate the incidence and risk factors of acute kidney injury (AKI) after percutaneous coronary intervention (PCI) in the oldest-old patients (≥80 years), particularly among those with baseline renal insufficiency and peri-operative hydration. This retrospective cohort study included patients ≥80 years undergoing PCI at two tertiary hospitals in China (hospitalized between January 2020 and December 2024). Baseline renal dysfunction was defined as eGFR < 60 mL/min/1.73 m2 on admission. The primary endpoint was AKI event after PCI according to KDIGO criteria. Secondary endpoints included in-hospital mortality, renal replacement therapy, and length of hospital stay. Logistic regression was applied to identify AKI risk factors. Restricted cubic splines (RCS, 4 knots) were used to explore the dynamic risk magnitude for AKI as baseline eGFR changes, adjusting for multivariable. Among the 995 patients included in the final analysis, the incidence of baseline renal insufficiency was 35.9% and that of AKI was 13.8%. Logistic regression showed that STEMI, NSTEMI, acute heart failure, baseline renal insufficiency, a higher neutrophil-to-lymphocyte ratio (NLR), and anemia were independent risk factors for AKI. Among those with baseline renal insufficiency, AKI incidence was 29.7%, and lower baseline eGFR, elevated NLR, and preoperative diuretic use were independent risk factors for AKI. RCS analysis revealed that the AKI risk was significantly increased when eGFR < 67.4 mL/min/1.73 m2, regardless of hydration therapy. Patients ≥ 80 years old with baseline renal failure confronted higher AKI risk after PCI procedure. Comprehensive strategies beyond hydration may be needed for AKI prevention in this fragile population.